Chemokines in Chronic Liver Allograft Dysfunction Pathogenesis and Potential Therapeutic Targets
Despite advances in immunosuppressive drugs, long-term success of liver transplantation is still limited by the development of chronic liver allograft dysfunction. Although the exact pathogenesis of chronic liver allograft dysfunction remains to be established, there is strong evidence that chemokin...
Main Authors: | Bin Liu, Jing Li, Lu-Nan Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2013/325318 |
Similar Items
-
CXCL4 Contributes to the Pathogenesis of Chronic Liver Allograft Dysfunction
by: Jing Li, et al.
Published: (2016-01-01) -
Expression of GSK-3β in renal allograft tissue and its significance in pathogenesis of chronic allograft dysfunction
by: Yan Qiang, et al.
Published: (2012-01-01) -
Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction
by: Cecilia Veraar, et al.
Published: (2021-03-01) -
Chemokine receptors as therapeutic targets in liver disease
by: Parker, Richard
Published: (2015) -
Chemokines and chemokine receptors in HIV infection: Role in pathogenesis and therapeutics
by: Suresh P, et al.
Published: (2006-01-01)